Find your next paid study

Virginia Commonwealth UniversityNCT05936931

Actual pay is set by the research site.

Colon PolypAdenomaSerrated Polyp+2 more

Six Versus Twelve Month SurveillAnce Following Resection of Nonpedunculated ColorectaL Polyps 20-50 mm IN Size Without High Grade Dysplasia (HGD)

The study will compare the use of a 6-month follow-up vs a 12-month follow-up after the removal of a large non-pedunculated polyp 20-50mm in size and without h…

Indiana UniversityNCT07198945

Actual pay is set by the research site.

Phase 2

A Phase 2, Randomized, Open-label Study of VVD-133214 in COmbination With Pembrolizumab Compared to Pembrolizumab Monotherapy in Participants With Advanced Colorectal Adenocarcinoma (CRC) Harboring Microsatellite Instability (MSI) and/or Deficient Mismatch Repair (DMMR)

Researchers are looking for a better way to treat people with advanced colorectal cancer. Colorectal cancer (cancer of the colon or rectum) is one of the most…

Colorectal Adenocarcinoma

Vividion Therapeutics, Inc.NCT07811193

~$75 – $2,800

Actual pay is set by the research site.

Phase 1

A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of TNG456 Monotherapy and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

This is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP l…

Non Small Cell Lung CancerGlioma Glioblastoma MultiformeGlioma, Malignant+4 more

Tango Therapeutics, Inc.NCT06810544

~$150 – $4,200

Actual pay is set by the research site.

Whole Genome SequencingAcute Myeloid LeukemiaMyelodysplastic Syndromes

A Prospective Study of Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

This is a single institution, prospective study of the whole genome sequencing assay, ChromoSeq. Using prospectively collected patient data, coupled with physi…

Washington University School of MedicineNCT04986657

Actual pay is set by the research site.

Phase 3

A Multicenter, Open-label, Phase 3 Extension Study to Evaluate the Long-term Efficacy and Safety in Participants Who Are Currently on Treatment in a Belzutifan Study (LITESPARK-043)

Researchers are looking for new ways to treat advanced solid tumors and von Hippel-Lindau (VHL)-related tumors: * Advanced means the cancer has spread to othe…

Von Hippel-Lindau DiseaseMalignant Neoplasms

Merck Sharp & Dohme LLCNCT07405164

~$50 – $2,100

Actual pay is set by the research site.

Tobacco UseTobacco Use Cessation

Automating Tobacco Cessation in Primary Care Via EHR Integration: A Non-Randomized Trial

This study focuses on improving how primary care teams identify patients who smoke and offer access to nicotine replacement therapy, or NRT. NRT includes medic…

University of PennsylvaniaNCT07735286

Actual pay is set by the research site.

Phase 3

A Phase 3, Double-Blind, Randomized, Two-Period, Multicenter, Placebo-Controlled, Efficacy and Safety Study of JNT-517 for the Treatment of Participants With Phenylketonuria

This Phase 3 study will evaluate the safety, effectiveness, tolerability, and how the body processes JNT-517 in children, adolescents, and adults with phenylke…

Phenylketonuria

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT06971731

~$50 – $2,100

Actual pay is set by the research site.

Phase 2

A Phase 2 Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants With Methamphetamine Use Disorder Not Seeking Treatment Receiving a Single Dose of Methamphetamine

The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infus…

Methamphetamine IntoxicationMethamphetamine DisordersMethamphetamine Abuse

Clear Scientific, Inc.NCT06721494

~$75 – $2,800

Actual pay is set by the research site.

Digital Screening and Brief Intervention for Perinatal Substance Use in Home Visiting

The goal of this study is to learn about whether digital screening and brief intervention can help address substance use in postpartum mothers who are enrolled…

Substance Use

The National Center on Addiction and Substance Abuse at Columbia UniversityNCT06624332

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Newly Diagnosed AML With an NPM1 Mutation

The purpose of this study is to assess if adding revumenib to standard chemotherapy improves outcomes in participants with AML with certain genetic mutations c…

Acute Myeloid Leukemias

Syndax PharmaceuticalsNCT07211958

~$50 – $2,100

Actual pay is set by the research site.

Phase 1

A Phase 1, Double-blinded, Randomized, Dose-repeating, Placebo-controlled, Cross-over Study to Assess the Safety and Preliminary Efficacy of Allogeneic ULSC on Disease Severity in Facioscapulohumeral Muscular Dystrophy (FSHD)

The goal of this clinical trial is to learn about how an umbilical cord lining-derived stem cell product (ULSC) performs when treating Facioscapulohumeral Musc…

FSHD - Facioscapulohumeral Muscular Dystrophy